---
$id: https://graph.org.ai/products/commodity/51272101
$type: Product
source: UNSPSC
code: "51272101"
title: "Parethoxycaine"
class: "51272100"
classTitle: "Anaesthetic benzoates"
family: "51270000"
familyTitle: "Anaesthetic drugs and related adjuncts and analeptics"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Parethoxycaine

**UNSPSC Code**: 51272101
**Class**: [Anaesthetic benzoates](Anaesthetic benzoates.mdx)
**Family**: [Anaesthetic drugs and related adjuncts and analeptics](../Anaesthetic drugs and related adjuncts and analeptics.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes an anesthetic agent with the molecular formula C15H23NO3, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 68E52E5J67, chemically known as benzoic acid, p-ethoxy-, 2-(diethylamino)ethyl ester but generally known as parethoxycaine, which bears US NIH Compound Identifier 7183. European Medicines Agency schedules Parethoxycaine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB09624MIG. The term PARETHOXYCAINE is an International Non-Proprietary Name. PARETHOXYCAINE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule parethoxycaine under HS 29221980 and SITC 51461. As of Q4 2014, PARETHOXYCAINE remains the US FDA Preferred Term for this commodity. Parethoxycaine bears US NLM identifiers UMLS ID C0771503 and NCI Concept Code C81402. SMILES: O(CCN(CC)CC)C(=O)C1CCC(OCC)CC1.

